Literature DB >> 31235623

Penicillin-Binding Protein Typing, Antibiotic Resistance Gene Identification, and Molecular Phylogenetic Analysis of Meropenem-Resistant Streptococcus pneumoniae Serotype 19A-CC3111 Strains in Japan.

Satoshi Nakano1, Takao Fujisawa2, Yutaka Ito3, Bin Chang4, Yasufumi Matsumura5, Masaki Yamamoto5, Shigeru Suga2, Makoto Ohnishi4, Miki Nagao5.   

Abstract

Since the introduction of pneumococcal conjugate vaccines, the prevalence of non-meropenem-susceptible pneumococci has been increasing in Japan. In an earlier study, we demonstrated that multidrug-resistant serotype 15A-ST63 in Japan has a specific pbp1a sequence (pbp1a-13) that could promote meropenem resistance. To trace the origin of pbp1a, we analyzed isolates of serotype 19A-CC3111, which is the most prevalent non-meropenem-susceptible clone in Japan. We analyzed a total of 119 serotype 19A-CC3111 strains recovered in Japan using whole-genome sequencing. Of the 119 isolates, 53 (44.5%) harbored pbp1a-13, indicating that the clone may be the primary reservoir of the pbp1a type and that the pbp1a region may be horizontally transferred between different serotype strains. The single acquisition of pbp1a-13 seemed to cause only penicillin resistance and not multidrug resistance; a combination of penicillin-binding protein (PBP) recombination in the pbp2b and/or pbp2x region(s) with acquisition of pbp1a-13 caused multidrug resistance. Conserved amino acid motif analysis suggested that the pbp1a 370SXXK, pbp2b 448SXN, and pbp2x 337SXXN motifs were the candidates for amino acid substitutions increasing the MICs of meropenem, cefotaxime, and penicillin. We identified a specific clone that was correlated with multidrug resistance, although no correlation was observed between phylogenetic trees generated using core genomes and those generated with only the cps locus. All tested isolates were highly erythromycin resistant, and most harbored mefE within macrolide efflux genetic assembly (MEGA) elements and ermB within Tn917, which was inserted within Tn916 and exhibited a structure identical to that of Tn2017.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  19A; Japan; PBP typing; ST3111; Streptococcus pneumoniaezzm321990; meropenem; multidrug resistance; pbp1azzm321990; pbp2bzzm321990; pbp2xzzm321990

Mesh:

Substances:

Year:  2019        PMID: 31235623      PMCID: PMC6709488          DOI: 10.1128/AAC.00711-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  Comparative genome analysis of high-level penicillin resistance in Streptococcus pneumoniae.

Authors:  Amelia G Tait-Kamradt; Melissa Cronan; Thomas J Dougherty
Journal:  Microb Drug Resist       Date:  2009-06       Impact factor: 3.431

3.  New composite genetic element of the Tn916 family with dual macrolide resistance genes in a Streptococcus pneumoniae isolate belonging to clonal complex 271.

Authors:  Maria Del Grosso; Romina Camilli; Balazs Libisch; Miklos Füzi; Annalisa Pantosti
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

4.  GET_HOMOLOGUES, a versatile software package for scalable and robust microbial pangenome analysis.

Authors:  Bruno Contreras-Moreira; Pablo Vinuesa
Journal:  Appl Environ Microbiol       Date:  2013-10-04       Impact factor: 4.792

5.  Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.

Authors:  José María Marimón; Adoración Valiente; María Ercibengoa; José M García-Arenzana; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  Rapid decrease of 7-valent conjugate vaccine coverage for invasive pneumococcal diseases in pediatric patients in Japan.

Authors:  Naoko Chiba; Miyuki Morozumi; Michi Shouji; Takeaki Wajima; Satoshi Iwata; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Microb Drug Resist       Date:  2013-03-12       Impact factor: 3.431

7.  Dramatic decrease of Streptococcus pneumoniae infections in Marseille, 2003-2014.

Authors:  C Abat; D Raoult; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-26       Impact factor: 3.267

8.  Demonstration of in vivo transfer of doxycycline resistance mediated by a novel transposon.

Authors:  Philip J Warburton; Richard M Palmer; Mark A Munson; William G Wade
Journal:  J Antimicrob Chemother       Date:  2007-09-13       Impact factor: 5.790

9.  Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States.

Authors:  B J Metcalf; S Chochua; R E Gertz; Z Li; H Walker; T Tran; P A Hawkins; A Glennen; R Lynfield; Y Li; L McGee; B Beall
Journal:  Clin Microbiol Infect       Date:  2016-08-17       Impact factor: 8.067

10.  Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.

Authors:  Pauline A Waight; Nicholas J Andrews; Nicholas J Ladhani; Carmen L Sheppard; Mary P E Slack; Elizabeth Miller
Journal:  Lancet Infect Dis       Date:  2015-05-17       Impact factor: 25.071

View more
  7 in total

1.  Analysis of phylogenetic markers for classification of a hydrogen peroxide producing Streptococcus oralis isolated from saliva by a newly devised differential medium.

Authors:  Ha Pham; Thi Dieu Thuy Tran; Youri Yang; Jae-Hyung Ahn; Hor-Gil Hur; Yong-Hak Kim
Journal:  J Microbiol       Date:  2022-07-14       Impact factor: 2.902

2.  Clearance of mixed biofilms of Streptococcus pneumoniae and methicillin-susceptible/resistant Staphylococcus aureus by antioxidants N-acetyl-L-cysteine and cysteamine.

Authors:  Julio Sempere; Mirella Llamosí; Federico Román; Darío Lago; Fernando González-Camacho; Covadonga Pérez-García; Jose Yuste; Mirian Domenech
Journal:  Sci Rep       Date:  2022-04-23       Impact factor: 4.996

3.  Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017.

Authors:  Satoshi Nakano; Takao Fujisawa; Yutaka Ito; Bin Chang; Yasufumi Matsumura; Masaki Yamamoto; Shigeru Suga; Makoto Ohnishi; Miki Nagao
Journal:  Emerg Infect Dis       Date:  2020-11       Impact factor: 6.883

4.  Early detection of drug-resistant Streptococcus pneumoniae and Haemophilus influenzae by quantitative flow cytometry.

Authors:  Takahiro Sawada; Masayuki Katayama; Shogo Takatani; Yoshiyuki Ohiro
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

5.  Genome-Wide Analysis of the Temporal Genetic Changes in Streptococcus pneumoniae Isolates of Genotype ST320 and Serotype 19A from South Korea.

Authors:  Jin Yang Baek; Sun Ju Kim; Juyoun Shin; Yeun-Jun Chung; Cheol-In Kang; Doo Ryeon Chung; Jae-Hoon Song; Kwan Soo Ko
Journal:  Microorganisms       Date:  2021-04-10

6.  Whole-Genome Analysis-Based Phylogeographic Investigation of Streptococcus pneumoniae Serotype 19A Sequence Type 320 Isolates in Japan.

Authors:  Satoshi Nakano; Takao Fujisawa; Bin Chang; Yutaka Ito; Hideki Akeda; Jiro Fujita; Yasufumi Matsumura; Masaki Yamamoto; Shigeru Suga; Kazunori Oishi; Miki Nagao; Makoto Ohnishi
Journal:  Antimicrob Agents Chemother       Date:  2021-12-20       Impact factor: 5.191

7.  Emergence of Meropenem Resistance Among Cefotaxime Non-susceptible Streptococcus pneumoniae: Evidence and Challenges.

Authors:  Rosemol Varghese; Soumya Basu; Ayyanraj Neeravi; Agilakumari Pragasam; V Aravind; Richa Gupta; Angel Miraclin; Sudha Ramaiah; Anand Anbarasu; Balaji Veeraraghavan
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.